Complement-Induced Impairment of Innate Immunity During Sepsis von Huber-Lang, Markus S, Younkin, Ellen M, Sarma, J. Vidya, McGuire, Stephanie R, Lu, Kristina T, Guo, Ren Feng, Padgaonkar, Vaishalee A, Curnutte, John T, Erickson, Richard, Ward, Peter A

Volltext

Protection of innate immunity by C5aR antagonist in septic mice von Huber‐Lang, Markus S., Riedeman, Niels C., Sarma, J. Vidya, Younkin, Ellen M., McGuire, Stephanie R., Laudes, Ines J., Lu, Kristina T., Guo, Ren‐Feng, Neff, Thomas A., Padgaonkar, Vaishalee A., Lambris, John D., Spruce, L., Mastellos, D., Zetoune, Firas S., Ward, Peter A.

Volltext

Structure-Function Relationships of Human C5a and C5aR von Huber-Lang, Markus S, Sarma, J. Vidya, McGuire, Stephanie R, Lu, Kristina T, Padgaonkar, Vaishalee A, Younkin, Ellen M, Guo, Ren Feng, Weber, Christian H, Zuiderweg, Erik R, Zetoune, Firas S, Ward, Peter A

Volltext

Role of C5a in Multiorgan Failure During Sepsis von Huber-Lang, Markus, Sarma, Vidya J, Lu, Kristina T, McGuire, Stephanie R, Padgaonkar, Vaishalee A, Guo, Ren-Feng, Younkin, Ellen M, Kunkel, Robin G, Ding, Jiabing, Erickson, Richard, Curnutte, John T, Ward, Peter A

Volltext

Molecular Signatures of Sepsis : Multiorgan Gene Expression Profiles of Systemic Inflammation von Chinnaiyan, Arul M, Huber-Lang, Markus, Kumar-Sinha, Chandan, Barrette, Terrence R, Shankar-Sinha, Sunita, Sarma, Vidya J, Padgaonkar, Vaishalee A, Ward, Peter A

Volltext

Roles for C-X-C chemokines and C5a in lung injury after hindlimb ischemia-reperfusion von Bless, Nicolas M, Warner, Roscoe L, Padgaonkar, Vaishalee A, Lentsch, Alex B, Czermak, Boris J, Schmal, Hagen, Friedl, Hans P, Ward, Peter A

Volltext

Differing Patterns of P-Selectin Expression in Lung Injury von Bless, Nicolas M., Tojo, Shinichiro J., Kawarai, Hiroko, Natsume, Yasuhiro, Lentsch, Alex B., Padgaonkar, Vaishalee A., Czermak, Boris J., Schmal, Hagen, Friedl, Hans P., Ward, Peter A.

Volltext

Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis von Guo, R F, Huber-Lang, M, Wang, X, Sarma, V, Padgaonkar, V A, Craig, R A, Riedemann, N C, McClintock, S D, Hlaing, T, Shi, M M, Ward, P A

Volltext

Protective effects of anti‐C5a peptide antibodies in experimental sepsis von Huber‐Lang, Markus S., Sarma, J. Vidya, McGuire, Stephanie R., Lu, Kristina T., Guo, Ren Feng, Padgaonkar, Vaishalee A., Younkin, Ellen M., Laudes, Ines J., Riedemann, Niels C., Younger, John G., Ward, Peter A.

Volltext

Molecular Signatures of Sepsis von Chinnaiyan, Arul M., Huber-Lang, Markus, Kumar-Sinha, Chandan, Barrette, Terrence R., Shankar-Sinha, Sunita, Sarma, Vidya J., Padgaonkar, Vaishalee A., Ward, Peter A.

Volltext

Roles for C-X-C chemokines and C5a in lung injury after hindlimb ischemia-reperfusion von BLESS, N. M, WARNER, R. L, PADGAONKAR, V. A, LENTSCH, A. B, CZERMAK, B. J, SCHMAL, H, FRIEDL, H. P, WARD, P. A

Volltext

Roles for C-X-C chemokines and C5a in lung injury after hindlimb ischemia-reperfusion von Bless, Nicolas M, Warner, Roscoe L, Padgaonkar, Vaishalee A, Lentsch, Alex B, Czermak, Boris J, Schmal, Hagen, Friedl, Hans P, Ward, Peter A

Volltext

Method of treating or inhibiting neutrophil chemotaxis by administering a MEK inhibitor von DEVALARAJA MADHAV NARASIMHA, LOW JOSEPH EDWIN, PADGAONKAR VAISHALEE A, BARAGI VIJAYKUMAR M

Volltext bestellen

Method of treating or inhibiting neutrophil chemotaxis by administering a MEK inhibitor von Baragi, Vijaykumar M, Devalaraja, Madhav Narasimha, Low, Joseph Edwin, Padgaonkar, Vaishalee A

Volltext bestellen

Method of treating or inhibiting neutrophil chemotaxis by administering a mek inhibitor von DEVALARAJA MADHAV NARASIMHA, LOW JOSEPH EDWIN, PADGAONKAR VAISHALEE A, BARAGI VIJAYKUMAR M

Volltext bestellen

METHOD FOR TREATING OR INHIBITING CHEMOTAXIS OF NEUTROPHIL BY ADMINISTERING MEK INHIBITOR von DEVALARAJA MADHAV NARASIMHA, LOW JOSEPH EDWIN, BARAGI VIJAYKUMAR MAHALINGAPPA, PADGAONKAR VAISHALEE A

Volltext bestellen

Efficacy and safety of the PI3Kδ inhibitor zandelisib (ME-401) on an intermittent schedule (IS) in patients with relapsed/refractory follicular lymphoma (FL) with progression of di... von Pagel, John M., Reddy, Nishitha, Jagadeesh, Deepa, Stathis, Anastasios, Asch, Adam Steven, Salman, Huda S., Kenkre, Vaishalee Padgaonkar, Soumerai, Jacob Drobnyk, Llorin-Sangalang, Judith, Gorbatchevsky, Igor, Li, Joanne, Zelenetz, Andrew David

Volltext

Tolerability and durable respones of the PI3Kδ inhibitor ME-401 administered on an intermittent schedule in relapsed/refractory (R/R) follicular lymphoma (FL) and other B-cell mali... von Zelenetz, Andrew David, Reddy, Nishitha, Jagadeesh, Deepa, Stathis, Anastasios, Salman, Huda S., Soumerai, Jacob D., Kenkre, Vaishalee Padgaonkar, Asch, Adam Steven, Llorin-Sangalang, Judith, Li, Joanne, Gorbatchevsky, Igor, Pagel, John M.

Volltext

Initial results of the combination of PI3Kδ inhibitor zandelisib (ME-401) and the BTK inhibitor zanubrutinib in patients (pts) with relapsed or refractory (R/R) B-cell malignancies... von Soumerai, Jacob Drobnyk, Jagadeesh, Deepa, Salman, Huda S., Lossos, Izidore S., Asch, Adam Steven, Reddy, Nishitha, Kenkre, Vaishalee Padgaonkar, Pagel, John M., Persky, Daniel O, Awan, Farrukh Tauseef, Magid Diefenbach, Catherine S., Huang, Wenying, Llorin-Sangalang, Judith, Gorbatchevsky, Igor, Zelenetz, Andrew David

Volltext

Results of the PI3Kδ inhibitor ME-401 alone or with rituximab in relapsed/refractory (R/R) follicular lymphoma (FL) von Zelenetz, Andrew David, Jagadeesh, Deepa, Reddy, Nishitha M., Stathis, Anastasios, Salman, Huda S., Asch, Adam Steven, Kenkre, Vaishalee Padgaonkar, Jhangiani, Haresh S., Iasonos, Alexia, Soumerai, Jacob D., Llorin, Judith, Pagel, John M.

Volltext